March 12, 2025 · Form 4 insider transaction
Nicaise Claude bought 9,746 shares of Sarepta Therapeutics, Inc. at $25.18 per share, a transaction worth $245.4K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.